Ströer SE & Co. KGaA (SAX)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 36.92 |
|---|---|
| 52-week range | 28.85 – 42.00 |
| Return, 1 month / 3 months | −1.1% / +0.7% |
| Return, 1 year / 3 years | −2.5% / −0.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 33.1% |
| Worst drawdown (1 year) | -23.2% |
| Average daily value traded | 2.96M EUR |
| Dividend yield | 5.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ströer SE & Co. KGaA is a German advertising company based in Cologne. It rents out advertising space on billboards, street furniture and transport sites, and it also runs digital advertising and online media businesses. Its customers are advertisers and brands that want to reach audiences outdoors and online, mainly in Germany and neighbouring European markets. The company combines traditional out-of-home advertising with digital marketing services and operates a portfolio of news and lifestyle websites.
On this site Ströer SE & Co. KGaA appears as a stock on the Deutsche Börse Xetra (Germany), code SAX, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ströer SE & Co. KGaA (SAX) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 36.92 on 27 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 149 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.5% and over the last three months it rose 0.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 5.5% | ||
| From 52-week high | -10.0% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.7% | ||
| 6-month return | 7.3% | ||
| 12-month return, skipping the last month | -1.4% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.2% | ||
| Liquidity | 83 · Strong | Trades actively. | |
| Average daily value traded | 2.96M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.0% |
|---|---|
| 1 month | −1.1% |
| 3 months | +0.7% |
| 6 months | +7.3% |
| 1 year | −2.5% |
| 3 years | −0.7% |
| 5 years | −34.6% |
Signals
| 50-day / 200-day average | 37.43 / 35.00 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.95 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | EUR 1.8500 |
| 5 Jun 2025 | EUR 2.3000 |
| 5 Jul 2024 | EUR 1.8500 |
| 12 Jun 2024 | EUR 1.8500 |
| 6 Jul 2023 | EUR 1.8500 |
| 23 Jun 2022 | EUR 2.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.